Genetic Predisposition to Disease
"Genetic Predisposition to Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.
Descriptor ID |
D020022
|
MeSH Number(s) |
C23.550.291.687.500 G05.380.355
|
Concept/Terms |
Genetic Predisposition to Disease- Genetic Predisposition to Disease
- Genetic Susceptibility
- Genetic Susceptibilities
- Susceptibilities, Genetic
- Susceptibility, Genetic
- Genetic Predisposition
- Genetic Predispositions
- Predispositions, Genetic
- Predisposition, Genetic
|
Below are MeSH descriptors whose meaning is more general than "Genetic Predisposition to Disease".
Below are MeSH descriptors whose meaning is more specific than "Genetic Predisposition to Disease".
This graph shows the total number of publications written about "Genetic Predisposition to Disease" by people in this website by year, and whether "Genetic Predisposition to Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 0 | 1 | 1 |
1998 | 1 | 1 | 2 |
1999 | 2 | 1 | 3 |
2000 | 4 | 3 | 7 |
2001 | 5 | 4 | 9 |
2002 | 4 | 7 | 11 |
2003 | 0 | 5 | 5 |
2004 | 4 | 5 | 9 |
2005 | 5 | 4 | 9 |
2006 | 2 | 10 | 12 |
2007 | 9 | 5 | 14 |
2008 | 5 | 12 | 17 |
2009 | 15 | 15 | 30 |
2010 | 9 | 12 | 21 |
2011 | 15 | 15 | 30 |
2012 | 13 | 12 | 25 |
2013 | 11 | 19 | 30 |
2014 | 14 | 23 | 37 |
2015 | 11 | 12 | 23 |
2016 | 7 | 19 | 26 |
2017 | 9 | 15 | 24 |
2018 | 7 | 11 | 18 |
2019 | 9 | 8 | 17 |
2020 | 8 | 3 | 11 |
2021 | 5 | 3 | 8 |
2022 | 0 | 5 | 5 |
2023 | 1 | 2 | 3 |
2024 | 1 | 4 | 5 |
2025 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genetic Predisposition to Disease" by people in Profiles.
-
Equity and Inclusion in Assessing Hereditary Cancer Risk: Insights From Excluded Communities, Structured Interviews, and Population Genetics. Cancer Control. 2025 Jan-Dec; 32:10732748251355825.
-
Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages. Ann Rheum Dis. 2025 Feb; 84(2):294-306.
-
Defining Mechanistic Links Between the Non-Coding Variant rs17673553 in CLEC16A and Lupus Susceptibility. Int J Mol Sci. 2025 Jan 01; 26(1).
-
Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group. Clin Cancer Res. 2024 Oct 15; 30(20):4566-4571.
-
Contribution of circulating Mfge8 to human T2DM and cardiovascular disease. Gene. 2024 Nov 15; 927:148712.
-
Bridging the Divide: From Universal Germline Testing Guidance to Real-World Implementation in Pancreatic Cancer Care. JCO Oncol Pract. 2024 Aug; 20(8):1012-1015.
-
Genetic variant rs1205 is associated with COVID-19 outcomes: The Strong Heart Study and Strong Heart Family Study. PLoS One. 2024; 19(4):e0302464.
-
The IFIH1-A946T risk variant promotes diabetes in a sex-dependent manner. Front Immunol. 2024; 15:1349601.
-
Families' experiences accessing care after genomic sequencing in the pediatric cancer context: "It's just been a big juggle". J Genet Couns. 2024 Dec; 33(6):1337-1350.
-
Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges. Front Med. 2023 Dec; 17(6):1135-1169.